Related references
Note: Only part of the references are listed.Different Intermediate Populations Formed by Tazobactam, Sulbactam, and Clavulanate Reacting with SHV-1 β-Lactamases: Raman Crystallographic Evidence
Matthew Kalp et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Sulbactam forms only minimal amounts of irreversible acrylate-enzyme with SHV-1 β-lactamase
Monica A. Totir et al.
BIOCHEMISTRY (2007)
Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 β-lactamase -: Insights into the mechanism of inhibition
D Sulton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 β-lactamase
PS Padayatti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
MMTSB Tool Set: enhanced sampling and multiscale modeling methods for applications in structural biology
M Feig et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2004)
Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 β-lactamase:: 1.63 Å crystal structure
PS Padayatti et al.
BIOCHEMISTRY (2004)
Following the reactions of mechanism-based inhibitors with β-lactamase by Raman crystallography
MS Helfand et al.
BIOCHEMISTRY (2003)
Inhibition of the SHV-1 β-lactamase by sulfones:: Crystallographic observation of two reaction intermediates with tazobactam
AP Kuzin et al.
BIOCHEMISTRY (2001)
Share Paper
